Molecules in VR: Investigating Cyclin-Dependent Kinase Selectivity

In this video, we evaluate differentiating non-selective and selective strategies targeting checkpoint cyclin-dependent kinases (CDKs). CDKs act as cell cycle checkpoint proteins regulating the progression from phase to phase impacting several pathways key to cancer development. Specific CDK inhibition can allow for targeted therapeutic strategies as well as further personalization of therapeutic approaches in cancer. We accomplish this through use of Nanome’s AutoDock Smina, RMSD, and Chemical Interactions plugins to describe the specificity of inhibition by different molecules. Nanome is the leader in collaborative structure-based design through virtual reality. Explore the nanoscale like never before and experience a more intuitive way to interact with small molecules and/or protein structures through the latest in visualization technology. Nanome enables global real-time collaboration and we’re working closely with some of the top pharmaceutical research facilities and academic research institutions. Whittaker, S. R., Mallinger, A., Workman, P. & Clarke, P. A. Inhibitors of Cyclin-Dependent Kinases as Cancer Therapeutics. Pharmacol Ther 173, 83–105 (2017). Wood, D. J. et al. Differences in the Conformational Energy Landscape of CDK1 and CDK2 Suggest a Mechanism for Achieving Selective CDK Inhibition. Cell Chemical Biology 26, (2019). Bettayeb, K. et al. CR8, a potent and selective, roscovitine-derived inhibitor of cyclin-dependent kinases. Oncogene 27, 5797–5807 (2008). Martin, M. P., Olesen, S. H., Georg, G. I. & Schönbrunn, E. Cyclin-Dependent Kinase Inhibitor Dinaciclib Interacts with the Acetyl-Lysine Recognition Site of Bromodomains. ACS Chem. Biol. 8, 2360–2365 (2013). Chen, P. et al. Spectrum and Degree of CDK Drug Interactions Predicts Clinical Performance. Mol Cancer Ther 15, 2273–2281 (2016). Talapati, S. R. et al. Structure of cyclin-dependent kinase 2 (CDK2) in complex with the specific and potent inhibitor CVT-313. Acta Cryst F 76, 350–356 (2020). Nanome is compatible with the HTC Vive and Oculus Rift. Get started today by downloading Nanome for free on: Oculus: SteamVR: Viveport To learn more visit: or, follow us on: Twitter & Insta: @nanome_inc Be sure to also check out our blockchain platform, Matryx, which will serve as the backend IP tracking mechanism for Nanome. More info at